Klingemann Hg

Rush University Medical Center — United States

Medicine · Health Sciences

21h-index7.1kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(19), Acute Myeloid Leukemia Research(12), Chronic Myeloid Leukemia Treatments(9), Immune Response and Inflammation(7), Hematological disorders and diagnostics(5)

Publications53 total

Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM
Cancer Cell International·2004· 6 citedOpen Access
Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia
Bone Marrow Transplantation·2003· 22 cited
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia
Bone Marrow Transplantation·2000· 76 cited
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation
Bone Marrow Transplantation·1998· 56 cited
196 Allogeneic bone marrow transplantation for adults with primary myelodysplastic syndrome: Evaluation of prognostic factors
Leukemia Research·1997
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
Blood·1995· 122 cited
1994 Consensus Conference on Acute GVHD Grading.
PubMed·1995· 5.1k cited
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation.
PubMed·1995· 50 cited
Transfer of the tumor necrosis factor alpha gene into hematopoietic progenitor cells as a model for site-specific cytokine delivery after marrow transplantation
Blood·1994· 13 citedOpen Access
Transfer of the tumor necrosis factor alpha gene into hematopoietic progenitor cells as a model for site-specific cytokine delivery after marrow transplantation
Blood·1994· 16 citedOpen Access
Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
PubMed·1994· 56 cited
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]
Blood·1994· 150 citedOpen Access
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]
Blood·1994· 121 citedOpen Access
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]
Blood·1994· 2 citedOpen Access
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]
Blood·1994· 217 citedOpen Access
Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
PubMed·1994· 3 cited
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours
British Journal of Cancer·1993· 31 citedOpen Access
Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
PubMed·1993· 13 cited
Response of therapy-related myelodysplasia to low-dose interleukin-2.
PubMed·1993· 20 cited
Autografting in chronic myeloid leukemia with cultured marrow.
PubMed·1992· 9 cited
page 1 of 3Next →

Frequent Co-authors

MJ Barnett(16), JD Shepherd(12), DE Reece(11), SH Nantel(9), GL Phillips(9), Donna E. Hogge(9), Phillips Gl(9), HJ Sutherland(7), Shepherd Jd(7), Barnett Mj(7), JJ Spinelli(5), R. Keith Humphries(5), PM Lansdorp(5), Reece De(5), CJ Eaves(4), Cynthia L. Toze(4), Nantel Sh(4), Sutherland Hj(4), RN Fairey(3), R. D. Gascoyne(3)